WRBY vs. STVN, GKOS, NARI, IRTC, TMDX, BLCO, INSP, SLNO, PRCT, and NVST
Should you be buying Warby Parker stock or one of its competitors? The main competitors of Warby Parker include Stevanato Group (STVN), Glaukos (GKOS), Inari Medical (NARI), iRhythm Technologies (IRTC), TransMedics Group (TMDX), Bausch + Lomb (BLCO), Inspire Medical Systems (INSP), Soleno Therapeutics (SLNO), PROCEPT BioRobotics (PRCT), and Envista (NVST). These companies are all part of the "medical equipment" industry.
Warby Parker vs. Its Competitors
Warby Parker (NYSE:WRBY) and Stevanato Group (NYSE:STVN) are both mid-cap consumer staples companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, analyst recommendations, valuation, media sentiment, profitability, earnings, risk and community ranking.
Stevanato Group has higher revenue and earnings than Warby Parker. Warby Parker is trading at a lower price-to-earnings ratio than Stevanato Group, indicating that it is currently the more affordable of the two stocks.
In the previous week, Warby Parker had 4 more articles in the media than Stevanato Group. MarketBeat recorded 6 mentions for Warby Parker and 2 mentions for Stevanato Group. Stevanato Group's average media sentiment score of 0.79 beat Warby Parker's score of 0.79 indicating that Stevanato Group is being referred to more favorably in the news media.
93.2% of Warby Parker shares are held by institutional investors. 18.2% of Warby Parker shares are held by insiders. Comparatively, 0.7% of Stevanato Group shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
Warby Parker received 24 more outperform votes than Stevanato Group when rated by MarketBeat users. However, 63.27% of users gave Stevanato Group an outperform vote while only 46.61% of users gave Warby Parker an outperform vote.
Stevanato Group has a net margin of 10.47% compared to Warby Parker's net margin of -4.39%. Stevanato Group's return on equity of 9.86% beat Warby Parker's return on equity.
Warby Parker presently has a consensus target price of $22.88, indicating a potential upside of 3.78%. Given Warby Parker's higher probable upside, equities analysts plainly believe Warby Parker is more favorable than Stevanato Group.
Warby Parker has a beta of 2.1, indicating that its share price is 110% more volatile than the S&P 500. Comparatively, Stevanato Group has a beta of 0.53, indicating that its share price is 47% less volatile than the S&P 500.
Summary
Stevanato Group beats Warby Parker on 12 of the 19 factors compared between the two stocks.
Get Warby Parker News Delivered to You Automatically
Sign up to receive the latest news and ratings for WRBY and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding WRBY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Warby Parker Competitors List
Related Companies and Tools
This page (NYSE:WRBY) was last updated on 6/14/2025 by MarketBeat.com Staff